Vita longa - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,676,712 | 2,028,216 | 2,144,313 | 2,408,777 | 2,664,281 | 3,243,903 | 3,864,543 | 4,147,473 |
| Profit before tax | 373,224 | 488,813 | 581,777 | 576,750 | 619,172 | 839,208 | 1,076,196 | 1,688,723 |
| Net profit | 364,116 | 477,757 | 571,026 | 549,048 | 606,646 | 823,197 | 1,050,872 | 1,413,923 |
| Equity | 1,057,886 | 1,016,698 | 1,176,668 | 1,125,717 | 1,132,362 | 1,355,559 | 1,706,431 | 1,920,354 |
| Liabilities | 20,676 | 9,660 | 20,436 | 143,007 | 132,513 | 143,123 | 225,980 | 466,511 |
| Non-current assets | 476,772 | 508,914 | 466,195 | 390,871 | 318,873 | 264,245 | 330,645 | 143,463 |
| Current assets | 700,214 | 624,083 | 857,860 | 991,010 | 1,003,408 | 1,280,357 | 1,613,269 | 2,259,824 |
| Total assets | 1,176,986 | 1,132,997 | 1,324,055 | 1,381,881 | 1,322,281 | 1,544,602 | 1,943,914 | 2,403,287 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 488,196 | 564,172 | 717,750 |
| Social insurance contributions | - | - | - | - | - | 454,870 | 527,177 | 604,086 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +14.7% | +21.0% | +5.7% | +12.3% | +10.6% | +21.8% | +19.1% | +7.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 30.9% | 42.2% | 43.1% | 39.7% | 45.9% | 53.3% | 54.1% | 58.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 34.4% | 47.0% | 48.5% | 48.8% | 53.6% | 60.7% | 61.6% | 73.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 21.7% | 23.6% | 26.6% | 22.8% | 22.8% | 25.4% | 27.2% | 34.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 22.3% | 24.1% | 27.1% | 23.9% | 23.2% | 25.9% | 27.8% | 40.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 19,254 | 22,536 | 24,934 | 29,495 | 30,219 | 35,324 | 41,854 | 41,753 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vita longa - Social security debts
The company had no debts to Sodra
Vita longa - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vita longa, UAB (code 135615787) is a Private Limited Liability Company operating in general medical practice activities. In 2025, the company generated revenue of €4.15M, up 7.3% year on year and 27.9% over two years. Net profit increased to €1.41M, following €823.2K in 2023 and €1.05M in 2024, showing a steady upward trajectory in both sales and earnings. The 2025 net profit margin reached 34.1%, compared with 25.4% in 2023 and 27.2% in 2024, indicating stronger profitability. The balance sheet also strengthened: total assets rose to €2.40M, equity to €1.92M, and liabilities to €466.5K. Equity represented 79.9% of assets, while debt-to-equity stood at 0.24, reflecting a conservative capital structure. Asset turnover was 1.73x in 2025. Productivity indicators were also solid, with revenue per employee of €41.9K and profit per employee of €14.3K.